These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7632324)

  • 21. Tyrosine hydroxylase-like (TH) immunoreactivity in Parkinson's disease and Alzheimer's disease.
    Torack RM; Morris JC
    J Neural Transm Park Dis Dement Sect; 1992; 4(2):165-71. PubMed ID: 1349211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colocalization and fluorescence resonance energy transfer between cdk5 and AT8 suggests a close association in pre-neurofibrillary tangles and neurofibrillary tangles.
    Augustinack JC; Sanders JL; Tsai LH; Hyman BT
    J Neuropathol Exp Neurol; 2002 Jun; 61(6):557-64. PubMed ID: 12071639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrastructural localization of butyrylcholinesterase on neurofibrillary degeneration sites in the brains of aged and Alzheimer's disease patients.
    Gómez-Ramos P; Bouras C; Morán MA
    Brain Res; 1994 Mar; 640(1-2):17-24. PubMed ID: 8004445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S6 kinase phosphorylated at T229 is involved in tau and actin pathologies in Alzheimer's disease.
    Sonoda Y; Tooyama I; Mukai H; Maeda K; Akiyama H; Kawamata T
    Neuropathology; 2016 Aug; 36(4):325-32. PubMed ID: 26582459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duration of neurofibrillary changes in the hippocampal pyramidal neurons.
    Bobinski M; Wegiel J; Tarnawski M; de Leon MJ; Reisberg B; Miller DC; Wisniewski HM
    Brain Res; 1998 Jul; 799(1):156-8. PubMed ID: 9666111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurofibrillary tangles have no obligatory predilection for acetylcholinesterase-rich neurons.
    Mesulam MM; Brimijoin S; Geula C
    Neurobiol Aging; 1994; 15(5):615-9. PubMed ID: 7824053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification.
    Takeda A; Smith MA; Avilá J; Nunomura A; Siedlak SL; Zhu X; Perry G; Sayre LM
    J Neurochem; 2000 Sep; 75(3):1234-41. PubMed ID: 10936206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tau kinases and phosphatases.
    Avila J
    J Cell Mol Med; 2008; 12(1):258-9. PubMed ID: 18366453
    [No Abstract]   [Full Text] [Related]  

  • 29. Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology.
    Nagy Z; Esiri MM; LeGris M; Matthews PM
    Acta Neuropathol; 1999 Apr; 97(4):346-54. PubMed ID: 10208273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease.
    Bondareff W; Harrington C; Wischik CM; Hauser DL; Roth M
    J Neuropathol Exp Neurol; 1994 Mar; 53(2):158-64. PubMed ID: 7509849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology.
    Su JH; Zhao M; Anderson AJ; Srinivasan A; Cotman CW
    Brain Res; 2001 Apr; 898(2):350-7. PubMed ID: 11306022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alzheimer's disease: is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology?
    Ransmayr G; Cervera P; Hirsch EC; Berger W; Fischer W; Agid Y
    Neuroscience; 1992; 47(4):843-51. PubMed ID: 1374541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of caspase-6 in aging and mild cognitive impairment.
    Albrecht S; Bourdeau M; Bennett D; Mufson EJ; Bhattacharjee M; LeBlanc AC
    Am J Pathol; 2007 Apr; 170(4):1200-9. PubMed ID: 17392160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of caspase-8 in the Alzheimer's disease brain.
    Rohn TT; Head E; Nesse WH; Cotman CW; Cribbs DH
    Neurobiol Dis; 2001 Dec; 8(6):1006-16. PubMed ID: 11741396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unraveling Alzheimer's. Scientists are close to figuring out how the disorder destroys brains. But will their knowledge save lives?
    Gorman C
    Time; 2000 Jul; 156(2):98-9. PubMed ID: 10977415
    [No Abstract]   [Full Text] [Related]  

  • 36. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease.
    Sheng JG; Mrak RE; Griffin WS
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):323-8. PubMed ID: 9600224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compartmentalized tau hyperphosphorylation and increased levels of kinases in transgenic mice.
    Götz J; Nitsch RM
    Neuroreport; 2001 Jul; 12(9):2007-16. PubMed ID: 11435938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.
    Amador-Ortiz C; Lin WL; Ahmed Z; Personett D; Davies P; Duara R; Graff-Radford NR; Hutton ML; Dickson DW
    Ann Neurol; 2007 May; 61(5):435-45. PubMed ID: 17469117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced expression of I-kappaB with neurofibrillary pathology in Alzheimer's disease.
    Yoshiyama Y; Arai K; Hattori T
    Neuroreport; 2001 Aug; 12(12):2641-5. PubMed ID: 11522940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropathological subtypes of Alzheimer's disease.
    Jellinger KA
    Acta Neuropathol; 2012 Jan; 123(1):153-4. PubMed ID: 22009303
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.